生化学工学およびバイオプロセス技術ジャーナル

Counter of Immunological Disease by Antibodies

Anjali K

The promise, for several years, of useful diagnostic and therapeutic monoclonal antibodies has begun to be realized. The applications to be used of antibodies, their derivatives and fragments continues to hold even more potential, as common obstacles to their use are resolved. The route that this biotechnology routinely follows is to first be introduced in specialized situations that do not involve radiolabeling. Then, because the security of each antibody product is established, uses targeting the precise site with radiolabeled diagnostic and therapeutic versions become viable.